All Stories

  1. Advances in Human Pathogen Control—A 21st Century Challenge
  2. Design and Optimization of Microbial Fuel Cells and Evaluation of a New Air-Breathing Cathode Based on Carbon Felt Modified with a Hydrogel—Ion Jelly®
  3. Identification of Burkholderia cenocepacia non-coding RNAs expressed during Caenorhabditis elegans infection
  4. Antitumoral and Antimicrobial Activities of Block Copolymer Micelles Containing Gold Bisdithiolate Complexes
  5. Comparison of Virulence-Factor-Encoding Genes and Genotype Distribution amongst Clinical Pseudomonas aeruginosa Strains
  6. Microbial Antigen Identification and Vaccine Delivery Systems
  7. Antibody-Based Immunotherapies as a Tool for Tackling Multidrug-Resistant Bacterial Infections
  8. Tuning the Biological Activity of Camphorimine Complexes through Metal Selection
  9. Broad Spectrum Functional Activity of Structurally Related Monoanionic Au(III) Bis(Dithiolene) Complexes
  10. Estrogens in wastewaters: Can different operating conditions improve their removal in anaerobic conditions?
  11. Bioelectricity generation using long-term operated biocathode: RFLP based microbial diversity analysis
  12. A Polyclonal Antibody Raised against the Burkholderia cenocepacia OmpA-like Protein BCAL2645 Impairs the Bacterium Adhesion and Invasion of Human Epithelial Cells In Vitro
  13. Synthesis and Characterization of Camphorimine Au(I) Complexes with a Remarkably High Antibacterial Activity towards B. contaminans and P. aeruginosa
  14. Bacterial Nosocomial Infections: Multidrug Resistance as a Trigger for the Development of Novel Antimicrobials
  15. Immunization and Immunotherapy Approaches against Pseudomonas aeruginosa and Burkholderia cepacia Complex Infections
  16. Sono-Biosynthesis and Characterization of AuNPs from Danube Delta Nymphaea alba Root Extracts and Their Biological Properties
  17. Impact of UASB reactors operation mode on the removal of estrone and 17α-ethinylestradiol from wastewaters
  18. Key Parameters on the Antibacterial Activity of Silver Camphor Complexes
  19. Extracellular RNAs in Bacterial Infections: From Emerging Key Players on Host-Pathogen Interactions to Exploitable Biomarkers and Therapeutic Targets
  20. Omics and Bioinformatics Approaches to Identify Novel Antigens for Vaccine Investigation and Development
  21. Characterization of the Burkholderia cenocepacia J2315 Surface-Exposed Immunoproteome
  22. Listeria monocytogenes as a Vector for Cancer Immunotherapy
  23. New Insights into Antibacterial Compounds: From Synthesis and Discovery to Molecular Mechanisms of Action
  24. Microbial Virulence Factors
  25. Deep Functional Profiling Facilitates the Evaluation of the Antibacterial Potential of the Antibiotic Amicoumacin
  26. Comparative Genomics and Evolutionary Analysis of RNA-Binding Proteins of Burkholderia cenocepacia J2315 and Other Members of the B. cepacia Complex
  27. New insights into the immunoproteome of B. cenocepacia J2315 using serum samples from cystic fibrosis patients
  28. On the path to gold: Monoanionic Au bisdithiolate complexes with antimicrobial and antitumor activities
  29. Gold(iii) bis(dithiolene) complexes: from molecular conductors to prospective anticancer, antimicrobial and antiplasmodial agents
  30. Antifungal, Antitumoral and Antioxidant Potential of the Danube Delta Nymphaea alba Extracts
  31. Investigations into the Structure/Antibacterial Activity Relationships of Cyclam and Cyclen Derivatives
  32. Ag(I) camphor complexes: antimicrobial activity by design
  33. Antimicrobial Activity of Silver Camphorimine Complexes against Candida Strains
  34. Determination of estrone and 17α-ethinylestradiol in digested sludge by ultrasonic liquid extraction and high-performance liquid chromatography with fluorescence detection
  35. Differential effects of Th17 cytokines during the response of neutrophils to Burkholderia cenocepacia outer membrane protein A
  36. Small Noncoding Regulatory RNAs from Pseudomonas aeruginosa and Burkholderia cepacia Complex
  37. Silver Camphor Imine Complexes: Novel Antibacterial Compounds from Old Medicines
  38. Postgenomic Approaches and Bioinformatics Tools to Advance the Development of Vaccines against Bacteria of the Burkholderia cepacia Complex
  39. Burkholderia puraquae sp. nov., a novel species of the Burkholderia cepacia complex isolated from hospital settings and agricultural soils
  40. Burkholderia cepacia Complex Infections Among Cystic Fibrosis Patients: Perspectives and Challenges
  41. Ag(I) camphorimine complexes with antimicrobial activity towards clinically important bacteria and species of the Candida genus
  42. Synthesis, antimicrobial activity and toxicity to nematodes of cyclam derivatives
  43. Burkholderia cepacia Complex Regulation of Virulence Gene Expression: A Review
  44. Variation of Burkholderia cenocepacia virulence potential during cystic fibrosis chronic lung infection
  45. The Burkholderia cenocepacia OmpA-like protein BCAL2958: identification, characterization, and detection of anti-BCAL2958 antibodies in serum from B. cepacia complex-infected Cystic Fibrosis patients
  46. Antibacterial activity of silver camphorimine coordination polymers
  47. Bioinformatics Applications in Life Sciences and Technologies
  48. Hfq: a multifaceted RNA chaperone involved in virulence
  49. Suitability of a Saccharomyces cerevisiae-based assay to assess the toxicity of pyrimethanil sprayed soils via surface runoff: Comparison with standard aquatic and soil toxicity assays
  50. Retraction for Ramos et al., The Second RNA Chaperone, Hfq2, Is Also Required for Survival under Stress and Full Virulence of Burkholderia cenocepacia J2315
  51. Retraction for Ramos et al., MtvR Is a Global Small Noncoding Regulatory RNA in Burkholderia cenocepacia
  52. Effects of operational shocks on key microbial populations for biogas production in UASB (Upflow Anaerobic Sludge Blanket) reactors
  53. Regulation of Hfq mRNA and Protein Levels in Escherichia coli and Pseudomonas aeruginosa by the Burkholderia cenocepacia MtvR sRNA
  54. Bioinformatics: A Molecular Microbiologist’s Perspective
  55. MtvR Is a Global Small Noncoding Regulatory RNA in Burkholderia cenocepacia
  56. Biochemical and Functional Studies on the Burkholderia cepacia Complex bceN Gene, Encoding a GDP-D-Mannose 4,6-Dehydratase
  57. Experimental identification of small non-coding regulatory RNAs in the opportunistic human pathogen Burkholderia cenocepacia J2315
  58. The Novel Cis-Encoded Small RNA h2cR Is a Negative Regulator of hfq2 in Burkholderia cenocepacia
  59. Synergistic action of azoreductase and laccase leads to maximal decolourization and detoxification of model dye-containing wastewaters
  60. Activated Sugar Precursors: Biosynthetic Pathways and Biological Roles of an Important Class of Intermediate Metabolites in Bacteria
  61. Enhancing wastewater degradation and biogas production by intermittent operation of UASB reactors
  62. A RNomics-based strategy identifies regulatory small RNAs in Burkholderia cepacia complex
  63. Identification and exploitation of Burkholderia cepacia complex virulence factors as potential antimicrobial targets
  64. The Second RNA Chaperone, Hfq2, Is Also Required for Survival under Stress and Full Virulence of Burkholderia cenocepacia J2315
  65. Microbial Ecology and Global Health
  66. Burkholderia cepaciaComplex: Emerging Multihost Pathogens Equipped with a Wide Range of Virulence Factors and Determinants
  67. The Burkholderia cenocepacia K56-2 pleiotropic regulator Pbr, is required for stress resistance and virulence
  68. Pathogenicity, virulence factors, and strategies to fight against Burkholderia cepacia complex pathogens and related species
  69. Distribution of Cepacian Biosynthesis Genes among Environmental and Clinical Burkholderia Strains and Role of Cepacian Exopolysaccharide in Resistance to Stress Conditions
  70. The hfq gene is required for stress resistance and full virulence of Burkholderia cepacia to the nematode Caenorhabditis elegans
  71. A new methodology combining PCR, cloning, and sequencing of clones discriminated by RFLP for the study of microbial populations: application to an UASB reactor sample
  72. Burkholderia cenocepacia J2315 acyl carrier protein: A potential target for antimicrobials' development?
  73. Functional analysis of the Burkholderia cenocepacia J2315 BceAJ protein with phosphomannose isomerase and GDP-d-mannose pyrophosphorylase activities
  74. Variation of the antimicrobial susceptibility profiles of Burkholderia cepacia complex clonal isolates obtained from chronically infected cystic fibrosis patients: a five-year survey in the major Portuguese treatment center
  75. Virulence of Burkholderia cepacia complex strains in gp91phox−/− mice
  76. The Burkholderia cepacia bceA gene encodes a protein with phosphomannose isomerase and GDP-d-mannose pyrophosphorylase activities
  77. Functional Analysis of Burkholderia cepacia Genes bceD and bceF, Encoding a Phosphotyrosine Phosphatase and a Tyrosine Autokinase, Respectively: Role in Exopolysaccharide Biosynthesis and Biofilm Formation
  78. Studies on the Involvement of the Exopolysaccharide Produced by Cystic Fibrosis-Associated Isolates of the Burkholderia cepacia Complex in Biofilm Formation and in Persistence of Respiratory Infections
  79. Identification and physical organization of the gene cluster involved in the biosynthesis of Burkholderia cepacia complex exopolysaccharide
  80. Molecular Analysis of Burkholderia cepacia Complex Isolates from a Portuguese Cystic Fibrosis Center: a 7-Year Study
  81. Macromolecular and solution properties of Cepacian: the exopolysaccharide produced by a strain of Burkholderia cepacia isolated from a cystic fibrosis patient
  82. Chromosomal organization and transcription analysis of genes in the vicinity of Pseudomonas aeruginosa glmM gene encoding phosphoglucosamine mutase
  83. Enzymes Leading to the Nucleotide Sugar Precursors for Exopolysaccharide Synthesis in Burkholderia cepacia
  84. Identification of the Pseudomonas aeruginosa glmM Gene, Encoding Phosphoglucosamine Mutase
  85. Structural Study of the Exopolysaccharide Produced by a Clinical Isolate of Burkholderia cepacia
  86. Pattern of changes in the activity of enzymes of GDP-D-mannuronic acid synthesis and in the level of transcription of algA, algC and algD genes accompanying the loss and emergence of mucoidy in Pseudomonas aeruginosa
  87. Oxygen-dependent upregulation of transcription of alginate genes algA, algC and algD in Pseudomonas aeruginosa
  88. Ribotyping of Pseudomonas aeruginosa isolates from patients and water springs and genome fingerprinting of variants concerning mucoidy
  89. Growth-phase-dependent alginate synthesis, activity of biosynthetic enzymes and transcription of alginate genes in Pseudomonas aeruginosa
  90. Growth-phase-dependent alginate synthesis, activity of biosynthetic enzymes and transcription of alginate genes in